FDA 483 - Southern Sales & Services Inc. - August 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Southern Sales & Services Inc., an OTC drug manufacturer and repacker in Fort Lauderdale, FL, revealed significant deficiencies in their quality system. The firm failed to follow its written stability testing program, did not conduct complete annual product reviews, and lacked an adequate continuous CGMP training program for employees, including production personnel. These issues indicate a lack of robust quality control and compliance with good manufacturing practices.
ID · ff54655e-d03e-4454-b405-0795ecde0648